Tech Company Inital Public Offerings
Progenity IPO
Progenity, based in Ann Arbor, offered its shares in an initial public offering on 6/19/2020.
Transaction Overview
Company Name
Announced On
6/19/2020
Transaction Type
IPO
Amount
$100,000,000
Proceeds Purpose
We intend to use the net proceeds of this offering as follows: approximately $60.0 to 65.0 million to support our operations; approximately $9.0 to 11.0 million to invest in our molecular testing research and development program; approximately $13.0 to 15.0 million to invest in research and development with respect to our precision medicine platform; and the remainder for working capital and general corporate purposes.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
5230 S. State Rd.
Ann Arbor, MI 48108
USA
Ann Arbor, MI 48108
USA
Phone
Website
Email Address
Not Recorded
Overview
Progenity (Nasdaq: PROG) is a CLIA-accredited laboratory and is accredited by the College of American Pathologists (CAP). We operate across the United States.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Harry Stylli
Chief Financial Officer
Eric d'Esparbes
Chief Information Officer
Troy Seelye
Chief Operating Officer
Damon Silvestry
Chief Scientific Officer
Matthew Cooper
VP - Bus. Development
Sami Shihabi
Browse more venture capital transactions:
Prev: 6/19/2020: Zerto venture capital transaction
Next: 6/19/2020: Apolicy venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs